Given that a hallmark clinical feature of CMT2A patients is length‐dependent motor neuropathy, assessing variations in the muscle‐nerve interactions induced by mutant MFN2 is of great interest for translational applications. Here, MFN2 is linked to Charcot-Marie-Tooth disease type 2A1.